Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term

被引：0
|
作者：
Liqi Chen
Guoli Li
Jieshou Li
Chaogang Fan
Jian Xu
Bo Wu
Kun Liu
Caihua Zhang
机构：
[1] Medical School of Nanjing University,Department of Surgery, Jinling Hospital
[2] Medical School of Nanjing University,Department of Medical Imaging, Jinling Hospital
[3] Medical School of Nanjing University,Department of Pathology, Jinling Hospital
[4] Gastrointestinal Surgery of Xuzhou Central Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2013年 / 71卷
关键词：
Gastric cancer; Preoperative chemotherapy; ERCC1; TS; Endarterial-intravenous coadministration; Real-time Fluorescent quantitative PCR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：921 / 928
页数：7
相关论文
共 50 条
  • [1] Correlation between expressions of ERCC1/TS mRNA and effects of gastric cancer to chemotherapy in the short term
    Chen, Liqi
    Li, Guoli
    Li, Jieshou
    Fan, Chaogang
    Xu, Jian
    Wu, Bo
    Liu, Kun
    Zhang, Caihua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 921 - 928
  • [2] Correlation of β-tubulin III and ERCC1 mRNA expression to chemotherapy outcome of gastric cancer patients with malignant ascites
    Ni, Xuefeng
    Wu, Ping
    Wu, Jun
    Ji, Mei
    Tian, Bo
    Jiang, Zhenxing
    Sun, Yue
    Xing, Xiaoxiao
    Jiang, Jingting
    Wu, Changping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11276 - 11283
  • [3] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Steffensen, K. D.
    Waldstrom, M.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 702 - 710
  • [4] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Waldstrom, M.
    Steffensen, K. D.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    APMIS, 2008, 116 (03) : 239 - 240
  • [5] Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
    Steffensen, K. D.
    Waldstrom, M.
    Jeppesen, U.
    Brandslund, I.
    Jakobsen, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer
    Liu, L.
    Li, C. H.
    Jin, T. F.
    Xu, D. Y.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 8722 - 8728
  • [7] SIGNIFICANCE OF TWO ERCC1 POLYMORPHISMS AND PRETHERAPEUTIC ERCC1 MRNA LEVELS IN COLORECTAL CANCER
    Kaskara, A. V.
    Antonacopoulou, A.
    Rigopoulos, A. G.
    Mavroudis, D.
    Scopa, C.
    Georgoulias, V.
    Kalofonos, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 137 - 138
  • [8] Correlation between ERCC1 expression and concurrent chemotherapy and radiotherapy in patients with locally advanced nasopharyngeal cancer
    Liang, R.
    Lin, Y.
    Liu, Z. H.
    Liao, X. L.
    Yuan, C. L.
    Liao, S. N.
    Li, Y. Q.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02): : 5804 - 5811
  • [9] Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy
    Li, Sheng
    Zhu, Liangjun
    Yao, Li
    Xia, Lei
    Pan, Liangxi
    BMC GASTROENTEROLOGY, 2014, 14
  • [10] Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy
    Sheng Li
    Liangjun Zhu
    Li Yao
    Lei Xia
    Liangxi Pan
    BMC Gastroenterology, 14
12345